EDGIO INC (EGIO)

US53261M2035 - Common Stock

9  -0.85 (-8.63%)

After market: 8.95 -0.05 (-0.56%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EGIO. EGIO was compared to 86 industry peers in the IT Services industry. EGIO has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EGIO is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

EGIO had negative earnings in the past year.
In the past year EGIO has reported a negative cash flow from operations.
In the past 5 years EGIO reported 4 times negative net income.
EGIO had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

EGIO has a worse Return On Assets (-33.86%) than 88.10% of its industry peers.
The Return On Equity of EGIO (-99.93%) is worse than 75.00% of its industry peers.
Industry RankSector Rank
ROA -33.86%
ROE -99.93%
ROIC N/A
ROA(3y)-17.23%
ROA(5y)-10.88%
ROE(3y)-38.66%
ROE(5y)-23.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of EGIO (29.14%) is worse than 64.29% of its industry peers.
EGIO's Gross Margin has declined in the last couple of years.
EGIO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.58%
GM growth 5Y-7.6%

1

2. Health

2.1 Basic Checks

EGIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
EGIO has more shares outstanding than it did 1 year ago.
EGIO has more shares outstanding than it did 5 years ago.
EGIO has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -2.08, we must say that EGIO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.08, EGIO is doing worse than 83.33% of the companies in the same industry.
A Debt/Equity ratio of 0.89 indicates that EGIO is somewhat dependend on debt financing.
EGIO has a worse Debt to Equity ratio (0.89) than 61.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z -2.08
ROIC/WACCN/A
WACC6.5%

2.3 Liquidity

EGIO has a Current Ratio of 0.85. This is a bad value and indicates that EGIO is not financially healthy enough and could expect problems in meeting its short term obligations.
EGIO has a worse Current ratio (0.85) than 83.33% of its industry peers.
EGIO has a Quick Ratio of 0.85. This is a bad value and indicates that EGIO is not financially healthy enough and could expect problems in meeting its short term obligations.
EGIO has a worse Quick ratio (0.85) than 80.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85

5

3. Growth

3.1 Past

The earnings per share for EGIO have decreased strongly by -33866.67% in the last year.
Looking at the last year, EGIO shows a very strong growth in Revenue. The Revenue has grown by 37.60%.
Measured over the past years, EGIO shows a quite strong growth in Revenue. The Revenue has been growing by 12.92% on average per year.
EPS 1Y (TTM)-33866.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-3400%
Revenue 1Y (TTM)37.6%
Revenue growth 3Y19.07%
Revenue growth 5Y12.92%
Revenue growth Q2Q-12.45%

3.2 Future

EGIO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.11% yearly.
Based on estimates for the next years, EGIO will show a quite strong growth in Revenue. The Revenue will grow by 9.99% on average per year.
EPS Next Y-4373.97%
EPS Next 2Y-276.4%
EPS Next 3Y106.46%
EPS Next 5Y26.11%
Revenue Next Year9.1%
Revenue Next 2Y4.48%
Revenue Next 3Y8.35%
Revenue Next 5Y9.99%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

EGIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EGIO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

EGIO's earnings are expected to grow with 106.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-276.4%
EPS Next 3Y106.46%

0

5. Dividend

5.1 Amount

No dividends for EGIO!.
Industry RankSector Rank
Dividend Yield N/A

EDGIO INC

NASDAQ:EGIO (5/3/2024, 7:00:01 PM)

After market: 8.95 -0.05 (-0.56%)

9

-0.85 (-8.63%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap52.74M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.86%
ROE -99.93%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 29.14%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-33866.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-4373.97%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)37.6%
Revenue growth 3Y19.07%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y